PhRMA Deal Remains Intact As Senate Majority Leaders Vote Against Drug Importation
This article was originally published in The Pink Sheet Daily
Executive Summary
The $80 billion deal the Rx industry struck as part of health care reform lives to see another day as drug importation fails on the Senate floor.